Viora

Herzliya, Israel Founded: 2003 • Age: 23 yrs Acquired By Sinclair Pharma
Provider of medical aesthetic solutions

About Viora

Viora is a company based in Herzliya (Israel) founded in 2003 was acquired by Sinclair Pharma in February 2022. Viora operates in a competitive market with competitors including Lumenis, Cutera, Solta, MedShift and InMode Aesthetic Solutions, among others.

Operational Areas
Key Metrics

Investors in Viora

Viora has secured backing from 1 investor. Prominent investors backing the company include Sinclair.

All
InvestorDescriptionFounded YearDomainLocation
Sinclair is recognized as a global medical aesthetics company.
–sinclairpharma.comLondon, United Kingdom
Premium access

Investor details for Viora

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Viora

2 dated milestones of Viora across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded Viora is founded.
  2. Exit Acquired by Sinclair Pharma.

Competitors of Viora

Viora operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lumenis, Cutera, Solta, MedShift and InMode Aesthetic Solutions, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lumenis.com1973Yokneam Illit, Israel––
Minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets
cutera.com1998Brisbane, United States–540
Energy-based aesthetic devices are developed for medical treatments.
solta.com1995Hayward, United States–6,355
Energy-based aesthetic medical devices are designed and marketed.
medshift.com2015Charlotte, United States$116M–
Medical practice management services
inmodemd.com2008Lake Forest, United States–171
Develops a portfolio of aesthetic solutions
cartessaaesthetics.com2017New York, United States$60M129
Aesthetic medical devices
almalasers.com1980Buffalo Grove, United States–48
Portfolio of optical, radiofrequency and ultrasound devices for aesthetic & medical applications
strataskinsciences.com1989Horsham, United States–114
Developer of medical devices to treat skin diseases
syneron-candela.com1970Marlborough, United States––
Candela Medical is engaged in developing aesthetic laser devices.
Premium access

Detailed competitors of Viora

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Viora

Websites that share an audience with Viora (vioramed.com).

Similar websites

Websites whose visitors overlap most with Viora. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
theperfectsmile.co.uk
theperfectsmile.co.uk
100%
–#976,742–
semcc.com
semcc.com
90%
–––
inmodemd.com
90%
48.1K#709,913View details
viorareaction.com
viorareaction.com
30%
–––

Latest news on Viora

Premium access

Complete news archive for Viora

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Viora

10 companies that operate in the same segment as Viora (Dermatology), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
2002Newark, New Jersey, United StatesUSD 154.56 MUSD 234.04 M597
Diagnostic tests for cancer prognosis are provided.
2008Friendswood, Texas, United StatesUSD 61.97 MUSD 344.23 M761
Developer of drugs for treating dermatology diseases
1908Copenhagen, DenmarkUSD 560.38 M––
Skincare, beauty, and wellness services provided by VLCC across multiple countries.
1989Delhi, Delhi, India–––
Adhesive patch biopsies for skin cancer detection are provided.
1996San Diego, California, United StatesUSD 24.37 MUSD 15.3 M259
AI-powered drug discovery platform for various diseases
2016New York, New York, United StatesUSD 608 M––
Immunotherapeutic solutions for dermatological conditions are developed.
2016Westlake Village, California, United StatesUSD 94.5 MUSD 376.07 M342
Targeted small molecules are developed for oncology treatments.
2010Singapore, SingaporeUSD 100 M––
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured.
2014Pune, Maharashtra, IndiaUSD 25.97 MUSD 18.15 M508
Novel dermatologic therapies are developed for skin conditions.
2012Malvern, Pennsylvania, United StatesUSD 82 MUSD 7.83 M64
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Viora

Viora was founded in 2003.

Viora is headquartered in Herzliya, Israel. It is registered at Herzliya, Central District, Israel.

Viora is the provider of medical aesthetic solutions for a wide range of applications. Based on their proprietary technologies such as CORE, SVC and PCR, it has developed non-invasive treatments for conditions such as skin tightening, body facial contouring, cellulite reduction, skin rejuvenation, acne clearance, skin resurfacing, stretch mark reduction, hair removal skin lightening. Its products include the V-Series multi-technology platforms (V30 V20) with light RF technologies; V-touch with fractional RF integrating SVC; Reaction with multi-frequency bi-polar RF CORE technology; Infusion for electromesotherapy trans-dermal delivery; Trios with IPL technology and, Pristine, crystal free microdermabrasion device.

Viora's top competitors include Lumenis, Cartessa Aesthetics and Cutera.

Viora has 1 investor. Key investors include Sinclair.

Yes. Viora was acquired by Sinclair Pharma in February 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available